Which compound should you recommend for supplementation?

Research presented at the virtual European Society of Human Genetics 2020 conference.

12 cohort studies involving more than 275,000 participants were evaluated.

Denosumab significantly decreased vertebral fracture risk, but nonvertebral fractures rose short-term.

Serum vitamin D concentration <10 ng/mL is a marker of severe LDD and LBP.

I risultati real-life di uno studio italiano confermano che la gestione della salute ossea ha un ruolo fondamentale per le donne con tumore al seno in trattamento ormonale adiuvante.

The study from Sweden finds a lower risk the year before TKR, increased risk the year after.

A cross-sectional cohort of >6000 middle-aged and older Chinese participants.

Patients with COPD have nearly 5x the risk for fractures and 2.6x the risk for osteoporosis.

Findings from a new randomised controlled trial of 160 obese older adults.

Patient-level pooled analysis of nearly 3000 randomized women with osteoporosis.

I risultati suggeriscono di sì, ma variano alquanto a seconda della sede e dello stato di menopausa.

The document reflects the outcomes of a consensus meeting involving experts from 17 countries

Apixaban stands out among DOACs for lower fracture incidence.